Odisha reports four new Covid-19 cases, totaling 49. Dr Nilakantha Mishra urges public to follow health guidelines amid 34 ...

Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.

Sanofi announced it is punting more than $9 billion to acquire Blueprint Medicines and its Ayvakit, BLU-808 and immunology ...

MOROGORO: TANZANIA has continued to make significant progress in strengthening its health sector, driven by a series of ...

Breakingviews provides financial professionals with unique agenda-setting insight on the major financial news stories as they ...

Late-stage results Otsuka presented in IgA nephropathy triggered a sell-off in Vera shares. Elsewhere, investors scrutinized ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

President Yoweri Museveni has assured Ugandans that the country is now unstoppable in terms of economic growth and ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

The acquisition includes a rare immunology disease medicine and an advanced and early-stage immunology pipeline.

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

Breakingviews provides financial professionals with unique agenda-setting insight on the major financial news stories as they ...